The Vital Role Of Start-Ups In Medtech Innovation
The MDR Threatens To Drive EU Start-ups To The US And The Outstanding EU MRA Is A Further Hurdle For Swiss Medtech Innovators
Focus On Switzerland – Part 4: The fragile nature of start-ups belies their value in medtech innovation, and they do not need unnecessary regulatory complications.
You may also be interested in...
Sir Simon Stevens leaves his position as chief executive of NHS England at the end of July after seven years of probably unmatched achievement. His will be big shoes to fill by Amanda Pritchard, his erstwhile deputy.
On this week’s podcast we highlight US Medicare reimbursement topics that industry should keep an eye on, and discuss important regulatory changes underway in the UK.
Cross-industry collaboration is the new focus of EU health care technology research funding activity. Under Horizon Europe, the Innovative Health Initiative will encourage convergence in health technology, and prioritize digital technologies and data analytics. No longer can EU-funded projects be pharma-only or medtech-only, said MedTech Europe’s Patrick Boisseau.